Predict your next investment

hemotune company logo
HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing

See what CB Insights has to offer

Founded Year



Incubator/Accelerator | Alive

Total Raised


About hemotune

hemotune develops a medical device for the purification of blood in acute care, focusing on crafting an efficient therapy for patients with sepsis.

hemotune Headquarter Location

Wagistrasse 27

Schlieren, 8952,


+41 77 512 36 98

Latest hemotune News

ETH spin-offs shine at Swiss Technology Award

Nov 20, 2020

November 20, 2020 News Schlieren ZH/Zurich - The three winners of the Swiss Technology Award have now been decided. With HeiQ and Hemotune, two of these are spin-offs from ETH Zurich. HeiQ specializes in textiles technologies, while Hemotune has developed a medical device for the purposes of blood purification. The Swiss Technology Award  has been presented for the 32nd time. The prize, which is awarded by the Swiss Economic Forum , aims to promote a culture of innovation within Switzerland and serves as recognition for exceptional firms in the three categories of Innovation Leaders, Start-ups and Inventors. In the category of Innovation Leaders, the company HeiQ from Schlieren in the canton of Zurich emerged victorious this year. The spin-off from the Swiss Federal Institute of Technology in Zurich ( ETH ) specializes in technologies for textiles. For example, the company has developed a technology that protects textiles against the SARS-CoV-2 virus, which is responsible for the disease COVID-19. HeiQ has been working with a series of partner firms in order to treat face masks and personal protective equipment (PPE) for doctors with the new antiviral protection. In the category of Start-ups, another ETH spin-off in the form of Hemotune was named as the winner. The company has developed a medical device for blood purification that combines the most recent scientific findings from the worlds of biomedicine and nanotechnology. The device is much more precise and efficient than previous methods, according to information from the company itself. It has primarily been designed for use in blood poisoning treatments. Back in August, Hemotune successfully raised a total of 5.1 million Swiss francs in fresh capital as part of a financing round. In the category of Inventors, the winning firm was a spin-off from the Swiss Federal Institute of Technology Lausanne ( EPFL ), namely Bloom Biorenewables . Bloom is working to develop a technology that will allow biomass to be used as an alternative to petroleum-based products in chemical manufacturing processes. Related news

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing hemotune

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

hemotune is included in 1 Expert Collection, including Medical Devices.


Medical Devices

7,891 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.